Risk of cardiovascular events following hemodialysis initiation: a self-controlled case series study

Minyoul Baik1, Jimin Jeon1, Joonsang Yoo1

  • 1Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.

PubMed

Insights

Initiating hemodialysis (HD) significantly increases cardiovascular disease (CVD) risk in chronic kidney disease (CKD) patients, especially within the first 10 days. Careful CVD risk evaluation is crucial for CKD patients requiring HD.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Patients with chronic kidney disease (CKD) face a heightened risk of cardiovascular disease (CVD).
  • The association between initiating hemodialysis (HD) and subsequent CVD risk in CKD patients requires thorough investigation.

Purpose of the Study:

  • To evaluate the association between hemodialysis initiation and cardiovascular disease (CVD) risk in patients with chronic kidney disease (CKD).

Main Methods:

  • A self-controlled case series design utilized a nationwide Korean health claims database.
  • Included CKD patients initiating HD between 2007-2019, with CVD events (stroke, myocardial infarction) from 2008-2020.
  • Risk periods were defined relative to HD initiation, with age-adjusted incidence rate ratios (IRR) calculated against a baseline.

Main Results:

  • Among 74,584 CKD patients on incident HD, 12,875 experienced CVD.
  • CVD risk elevated post-HD initiation, peaking within the first 10 days (IRR 2.95).
  • Ischemic stroke and MI risks decreased at 1-2 months, but hemorrhagic stroke risk remained elevated for 5 months.

Conclusions:

  • Hemodialysis initiation is associated with increased CVD risk in CKD patients.
  • A careful CVD risk assessment is essential for CKD patients undergoing HD.
  • The temporal pattern of CVD risk varies by stroke type following HD initiation.
Abstract

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
269
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
280
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
739